{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:12:01Z","timestamp":1790313121514,"version":"4.1.0"},"reference-count":84,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015326","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS129659"],"award-info":[{"award-number":["R01 NS129659"]}],"id":[{"id":"10.13039\/100015326","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Leigh Syndrome UMDF award"},{"name":"TPI Deficiency Research Fund"},{"name":"Oliver Amaya Cruz Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Background\/Objectives: Primary metabolic diseases including mitochondrial encephalomyopathies (ME), glycolytic enzymopathies, and disorders of lipid and amino acid metabolism can manifest with severe neurological and neuromuscular symptoms. Conversely, it is increasingly appreciated that primary neurodegenerative diseases can have metabolic etiology and pathophysiology. Pharmacological treatments have limited benefit for these classes of diseases, but dietary therapy is increasingly recognized as a tool for bolstering metabolic processes that can ameliorate neurological symptoms. The ketogenic diet is the best-established example, having long been used as a therapy for epilepsy. Replenishing metabolic intermediates (anaplerosis) especially substrates of the citric acid cycle (CAC) is currently being explored, with ongoing clinical trials of simple metabolic intermediates such as oxaloacetate or NAD+ to treat neurodegenerative diseases. We have shown ketogenic and anaplerotic therapies to be effective in a Drosophila model of ME; however, the full therapeutic potential and role of the CAC in neuronal health is still not well understood. Methods: Here, we have used genetic, behavioral, and dietary approaches to elucidate critical links between the CAC and neurological function. Results: We have found that stimulating the CAC can improve and sustain neurological health in the face of severe metabolic disease, and that its functions include a previously unrecognized role in maintaining normal circadian rhythms, whose disruption is often an early indicator or complicating factor in neurological and neurodegenerative disease. We investigated the hypothesis that the production of GTP by the CAC may be an important mechanistic contributor to the role of the CAC in neurological health and disease, and may underlie its therapeutic potential. Conclusions: Overall, our findings expand our understanding of the role of the CAC in neurological health and disease, support its development as a therapeutic target, and provide a foundation for further studies investigating the intersection between neurological disease and metabolic function.<\/jats:p>","DOI":"10.3390\/genes17020192","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T10:02:57Z","timestamp":1770199377000},"page":"192","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Citric Acid Cycle Modulates Neurologic Health and Is a Therapeutic Target of Dietary and Genetic Modification in Metabolic Disease"],"prefix":"10.3390","volume":"17","author":[{"given":"Keri J.","family":"Fogle","sequence":"first","affiliation":[{"name":"Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15260, USA"},{"name":"Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA 15260, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1825-9569","authenticated-orcid":false,"given":"Sarah K.","family":"Lindley","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15260, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidney L.","family":"Satterfield","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15260, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beakal A.","family":"Amsalu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15260, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2669-4789","authenticated-orcid":false,"given":"Joseph R.","family":"Figura","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15260, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha L.","family":"Eicher","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15260, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke A.","family":"Scherz","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15260, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5923-4771","authenticated-orcid":false,"given":"Michael J.","family":"Palladino","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15260, USA"},{"name":"Pittsburgh Institute for Neurodegenerative Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA 15260, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.neuropharm.2012.05.012","article-title":"Energy depletion in seizures: Anaplerosis as a strategy for future therapies","volume":"69","author":"Kovac","year":"2013","journal-title":"Neuropharmacology"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Singh, A., Kukreti, R., Saso, L., and Kukreti, S. (2019). Oxidative Stress: A Key Modulator in Neurodegenerative Diseases. Molecules, 24.","DOI":"10.3390\/molecules24081583"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41392-025-02141-x","article-title":"Energy metabolism in health and diseases","volume":"10","author":"Liu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.freeradbiomed.2022.09.032","article-title":"Altered glucose metabolism in Alzheimer\u2019s disease: Role of mitochondrial dysfunction and oxidative stress","volume":"193","author":"Dewanjee","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Ardanaz, C.G., Ramirez, M.J., and Solas, M. (2022). Brain Metabolic Alterations in Alzheimer\u2019s Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073785"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: Recent advances","volume":"15","author":"Wang","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S453","DOI":"10.3233\/JAD-220514","article-title":"The Novel Role of Mitochondrial Citrate Synthase and Citrate in the Pathophysiology of Alzheimer\u2019s Disease","volume":"94","author":"Chhimpa","year":"2023","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"101868","DOI":"10.1016\/j.mito.2024.101868","article-title":"Involvement of mitochondria in Alzheimer\u2019s disease pathogenesis and their potential as targets for phytotherapeutics","volume":"76","author":"Maruthiyodan","year":"2024","journal-title":"Mitochondrion"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11910-018-0829-3","article-title":"Mitochondrial Dysfunction in Parkinson\u2019s Disease: New Mechanistic Insights and Therapeutic Perspectives","volume":"18","author":"Park","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5607\/en.2015.24.2.103","article-title":"Mitochondrial Dysfunction in Parkinson\u2019s Disease","volume":"24","author":"Moon","year":"2015","journal-title":"Exp. Neurobiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1007\/s12035-020-01926-1","article-title":"The Role of Mitochondria in Neurodegenerative Diseases: The Lesson from Alzheimer\u2019s Disease and Parkinson\u2019s Disease","volume":"57","author":"Corti","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Choong, C.J., and Mochizuki, H. (2023). Involvement of Mitochondria in Parkinson\u2019s Disease. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242317027"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"7674","DOI":"10.1038\/s41467-023-42862-7","article-title":"A reversible state of hypometabolism in a human cellular model of sporadic Parkinson\u2019s disease","volume":"14","author":"Schmidt","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/14737175.2018.1465410","article-title":"Oxidative stress in epilepsy","volume":"18","author":"Geronzi","year":"2018","journal-title":"Expert. Rev. Neurother."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Fabisiak, T., and Patel, M. (2022). Crosstalk between neuroinflammation and oxidative stress in epilepsy. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.976953"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.eplepsyres.2009.09.020","article-title":"Mitochondria, oxidative stress, and temporal lobe epilepsy","volume":"88","author":"Waldbaum","year":"2010","journal-title":"Epilepsy Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s12035-020-02175-y","article-title":"TRAK1-Mediated Abnormality of Mitochondrial Fission Increases Seizure Susceptibility in Temporal Lobe Epilepsy","volume":"58","author":"Wu","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Wells, J., Swaminathan, A., Paseka, J., and Hanson, C. (2020). Efficacy and Safety of a Ketogenic Diet in Children and Adolescents with Refractory Epilepsy-A Review. Nutrients, 12.","DOI":"10.3390\/nu12061809"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1194\/jlr.R048975","article-title":"Ketogenic diets, mitochondria, and neurological diseases","volume":"55","author":"Gano","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Stafstrom, C.E., and Rho, J.M. (2012). The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front. Pharmacol., 3.","DOI":"10.3389\/fphar.2012.00059"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Borowicz-Reutt, K., Krawczyk, M., and Czernia, J. (2024). Ketogenic Diet in the Treatment of Epilepsy. Nutrients, 16.","DOI":"10.3390\/nu16091258"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1212\/WNL.56.10.1340","article-title":"Epileptic phenotypes associated with mitochondrial disorders","volume":"56","author":"Canafoglia","year":"2001","journal-title":"Neurology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1056\/NEJMra022567","article-title":"Mitochondrial respiratory-chain diseases","volume":"348","author":"DiMauro","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/arclin\/acu016","article-title":"Mitochondrial DNA mutations and cognition: A case-series report","volume":"29","author":"Trampush","year":"2014","journal-title":"Arch. Clin. Neuropsychol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00415-015-7884-3","article-title":"Mitochondrial disease: Genetics and management","volume":"263","author":"Ng","year":"2016","journal-title":"J. Neurol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1042\/bst0300030","article-title":"Triosephosphate isomerase deficiency: A neurodegenerative misfolding disease","volume":"30","author":"Olah","year":"2002","journal-title":"Biochem. Soc. Trans."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.5664\/jcsm.4212","article-title":"Sleep disorders associated with primary mitochondrial diseases","volume":"10","author":"Ramezani","year":"2014","journal-title":"J. Clin. Sleep. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"fcab063","DOI":"10.1093\/braincomms\/fcab063","article-title":"Dominant ACO2 mutations are a frequent cause of isolated optic atrophy","volume":"3","author":"Charif","year":"2021","journal-title":"Brain Commun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.cellsig.2014.03.030","article-title":"Krebs cycle dysfunction shapes epigenetic landscape of chromatin: Novel insights into mitochondrial regulation of aging process","volume":"26","author":"Salminen","year":"2014","journal-title":"Cell. Signal."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Magro, G., Laterza, V., and Tosto, F. (2025). Leigh Syndrome: A Comprehensive Review of the Disease and Present and Future Treatments. Biomedicines, 13.","DOI":"10.20944\/preprints202503.0699.v1"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0022-3476(05)83431-6","article-title":"Maternally inherited Leigh syndrome","volume":"122","author":"Ciafaloni","year":"1993","journal-title":"J. Pediatr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13023-020-1297-9","article-title":"Molecular basis of Leigh syndrome: A current look","volume":"15","author":"Baldo","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/CND.0000000000000422","article-title":"Neuropathy, Ataxia, and Retinitis Pigmentosa Syndrome","volume":"24","author":"Finsterer","year":"2023","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Celotto, A.M., Chiu, W.K., Van Voorhies, W., and Palladino, M.J. (2011). Modes of metabolic compensation during mitochondrial disease using the Drosophila model of ATP6 dysfunction. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0025823"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1523\/JNEUROSCI.4162-05.2006","article-title":"Mitochondrial encephalomyopathy in Drosophila","volume":"26","author":"Celotto","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.nbscr.2019.01.003","article-title":"Sleep and circadian defects in a Drosophila model of mitochondrial encephalomyopathy","volume":"6","author":"Fogle","year":"2019","journal-title":"Neurobiol. Sleep. Circadian Rhythm."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.nbd.2010.05.009","article-title":"Modeling mitochondrial encephalomyopathy in Drosophila","volume":"40","author":"Palladino","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/01677063.2016.1252765","article-title":"The ATP-sensitive K channel is seizure protective and required for effective dietary therapy in a model of mitochondrial encephalomyopathy","volume":"30","author":"Fogle","year":"2016","journal-title":"J. Neurogenet."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ymgme.2019.01.008","article-title":"Ketogenic and anaplerotic dietary modifications ameliorate seizure activity in Drosophila models of mitochondrial encephalomyopathy and glycolytic enzymopathy","volume":"126","author":"Fogle","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e07247","DOI":"10.7554\/eLife.07247","article-title":"Selections that isolate recombinant mitochondrial genomes in animals","volume":"4","author":"Ma","year":"2015","journal-title":"eLife"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/ng.3587","article-title":"Selfish drive can trump function when animal mitochondrial genomes compete","volume":"48","author":"Ma","year":"2016","journal-title":"Nat. Genet."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/genetics\/100.4.597","article-title":"Indirect Suppression Involving Behavioral Mutants with Altered Nerve Excitability in Drosophila melanogaster","volume":"100","author":"Ganetzky","year":"1982","journal-title":"Genetics"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s42003-018-0031-9","article-title":"ShinyR-DAM: A program analyzing Drosophila activity, sleep and circadian rhythms","volume":"1","author":"Cichewicz","year":"2018","journal-title":"Commun. Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e14368","DOI":"10.1111\/acel.14368","article-title":"Ketogenic beta-hydroxybutyrate regulates beta-hydroxybutyrylation of TCA cycle-associated enzymes and attenuates disease-associated pathologies in Alzheimer\u2019s mice","volume":"24","author":"Han","year":"2025","journal-title":"Aging Cell"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Imdad, K., Abualait, T., Kanwal, A., AlGhannam, Z.T., Bashir, S., Farrukh, A., Khattak, S.H., Albaradie, R., and Bashir, S. (2022). The Metabolic Role of Ketogenic Diets in Treating Epilepsy. Nutrients, 14.","DOI":"10.3390\/nu14235074"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1471-4159.2008.05460.x","article-title":"The ketogenic diet increases mitochondrial glutathione levels","volume":"106","author":"Jarrett","year":"2008","journal-title":"J. Neurochem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neulet.2015.07.034","article-title":"How does the ketogenic diet induce anti-seizure effects?","volume":"637","author":"Rho","year":"2017","journal-title":"Neurosci. Lett."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1743-7075-7-74","article-title":"The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma","volume":"7","author":"Stafford","year":"2010","journal-title":"Nutr. Metab."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1001\/jamaneurol.2014.1584","article-title":"Triheptanoin for glucose transporter type I deficiency (G1D): Modulation of human ictogenesis, cerebral metabolic rate, and cognitive indices by a food supplement","volume":"71","author":"Pascual","year":"2014","journal-title":"JAMA Neurol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.eplepsyres.2011.12.013","article-title":"Triheptanoin in acute mouse seizure models","volume":"99","author":"Thomas","year":"2012","journal-title":"Epilepsy Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.nbd.2010.07.017","article-title":"Anticonvulsant effects of a triheptanoin diet in two mouse chronic seizure models","volume":"40","author":"Willis","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1534\/genetics.106.063206","article-title":"Drosophila model of human inherited triosephosphate isomerase deficiency glycolytic enzymopathy","volume":"174","author":"Celotto","year":"2006","journal-title":"Genetics"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.nbd.2010.08.011","article-title":"Hsp70- and Hsp90-mediated proteasomal degradation underlies TPI sugarkill pathogenesis in Drosophila","volume":"40","author":"Hrizo","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Roland, B.P., Zeccola, A.M., Larsen, S.B., Amrich, C.G., Talsma, A.D., Stuchul, K.A., Heroux, A., Levitan, E.S., VanDemark, A.P., and Palladino, M.J. (2016). Structural and Genetic Studies Demonstrate Neurologic Dysfunction in Triosephosphate Isomerase Deficiency Is Associated with Impaired Synaptic Vesicle Dynamics. PLoS Genet., 12.","DOI":"10.1371\/journal.pgen.1005941"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1534\/genetics.106.057463","article-title":"Metabolic disruption in Drosophila bang-sensitive seizure mutants","volume":"173","author":"Fergestad","year":"2006","journal-title":"Genetics"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s10545-011-9294-8","article-title":"Structural basis of fumarate hydratase deficiency","volume":"34","author":"Picaud","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/088307380201703S01","article-title":"Defects of pyruvate metabolism and the Krebs cycle","volume":"17","year":"2002","journal-title":"J. Child. Neurol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/labinvest.2017.125","article-title":"The actions of NME1\/NDPK-A and NME2\/NDPK-B as protein kinases","volume":"98","author":"Attwood","year":"2018","journal-title":"Lab. Invest."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11010-009-0120-7","article-title":"The mammalian Nm23\/NDPK family: From metastasis control to cilia movement","volume":"329","author":"Boissan","year":"2009","journal-title":"Mol. Cell. Biochem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1023\/A:1005545214937","article-title":"Role of AWD\/nucleoside diphosphate kinase in Drosophila development","volume":"32","author":"Timmons","year":"2000","journal-title":"J. Bioenerg. Biomembr."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nbd.2016.08.002","article-title":"Ketone ester supplementation attenuates seizure activity, and improves behavior and hippocampal synaptic plasticity in an Angelman syndrome mouse model","volume":"96","author":"Ciarlone","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"eady9811","DOI":"10.1126\/sciadv.ady9811","article-title":"NAD(+) reverses Alzheimer\u2019s neurological deficits via regulating differential alternative RNA splicing of EVA1C","volume":"11","author":"Ai","year":"2025","journal-title":"Sci. Adv."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"E1876","DOI":"10.1073\/pnas.1718819115","article-title":"NAD(+) supplementation normalizes key Alzheimer\u2019s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency","volume":"115","author":"Hou","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1126\/science.aaf2693","article-title":"NAD(+) repletion improves mitochondrial and stem cell function and enhances life span in mice","volume":"352","author":"Zhang","year":"2016","journal-title":"Science"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbacli.2016.03.005","article-title":"Tolerability and pharmacokinetics of oxaloacetate 100 mg capsules in Alzheimer\u2019s subjects","volume":"5","author":"Swerdlow","year":"2016","journal-title":"BBA Clin."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tem.2021.11.003","article-title":"Alpha-Ketoglutarate dietary supplementation to improve health in humans","volume":"33","author":"Gyanwali","year":"2022","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40035-023-00336-2","article-title":"Combined metabolic activators improve cognitive functions in Alzheimer\u2019s disease patients: A randomised, double-blinded, placebo-controlled phase-II trial","volume":"12","author":"Yulug","year":"2023","journal-title":"Transl. Neurodegener."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13195-025-01693-y","article-title":"Pharmacokinetic and pharmacodynamic assessment of oral nicotinamide in the NEAT clinical trial for early Alzheimer\u2019s disease","volume":"17","author":"Ketron","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"E417","DOI":"10.1152\/ajpendo.00242.2023","article-title":"Evaluation of safety and effectiveness of NAD in different clinical conditions: A systematic review","volume":"326","author":"Gindri","year":"2024","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/alz.12156","article-title":"Safety and target engagement profile of two oxaloacetate doses in Alzheimer\u2019s patients","volume":"17","author":"Vidoni","year":"2021","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1152\/physrev.00016.2012","article-title":"Metabolism and the circadian clock converge","volume":"93","year":"2013","journal-title":"Physiol. Rev."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.cell.2013.11.034","article-title":"Reprogramming of the circadian clock by nutritional challenge","volume":"155","author":"Patel","year":"2013","journal-title":"Cell"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Emery, P. (2015). Connecting Circadian Genes to Neurodegenerative Pathways in Fruit Flies. PLoS Genet., 11.","DOI":"10.1371\/journal.pgen.1005266"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Gangitano, E., Gnessi, L., Lenzi, A., and Ray, D. (2021). Chronobiology and Metabolism: Is Ketogenic Diet Able to Influence Circadian Rhythm?. Front. Neurosci., 15.","DOI":"10.3389\/fnins.2021.756970"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Hood, S., and Amir, S. (2017). Neurodegeneration and the Circadian Clock. Front. Aging Neurosci., 9.","DOI":"10.3389\/fnagi.2017.00170"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"20455","DOI":"10.1073\/pnas.1313336110","article-title":"Flavin reduction activates Drosophila cryptochrome","volume":"110","author":"Vaidya","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1126\/science.1060698","article-title":"Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors","volume":"293","author":"Rutter","year":"2001","journal-title":"Science"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Grover, D., Ford, D., Brown, C., Hoe, N., Erdem, A., Tavare, S., and Tower, J. (2009). Hydrogen peroxide stimulates activity and alters behavior in Drosophila melanogaster. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0007580"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1101\/gad.237081.113","article-title":"The circadian clock regulates rhythmic activation of the NRF2\/glutathione-mediated antioxidant defense pathway to modulate pulmonary fibrosis","volume":"28","author":"Gibbs","year":"2014","journal-title":"Genes. Dev."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/dom.12519","article-title":"Interplay between cellular redox oscillations and circadian clocks","volume":"17","author":"Rey","year":"2015","journal-title":"Diabetes Obes. Metab."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Klaessens, S., Stroobant, V., De Plaen, E., and Van den Eynde, B.J. (2022). Systemic tryptophan homeostasis. Front. Mol. Biosci., 9.","DOI":"10.3389\/fmolb.2022.897929"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"16359","DOI":"10.1073\/pnas.0705510104","article-title":"Beta-nicotinamide adenine dinucleotide is an inhibitory neurotransmitter in visceral smooth muscle","volume":"104","author":"Hwang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s12276-021-00646-3","article-title":"Redefining differential roles of MAO-A in dopamine degradation and MAO-B in tonic GABA synthesis","volume":"53","author":"Cho","year":"2021","journal-title":"Exp. Mol. Med."}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/17\/2\/192\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T10:06:46Z","timestamp":1770199606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/17\/2\/192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":84,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["genes17020192"],"URL":"https:\/\/doi.org\/10.3390\/genes17020192","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]}}}